About Medrexcare Pharma Private Limited
Data last updated:
Medrexcare Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 September 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2012PTC083331. Its GSTIN is 36AAICM1811G1ZQ (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anitha Puritipati and Bantroth Rammohan Reddy.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Ground & First Floor H.No:4 – 32 – 41/149/1 Raghavendra Nagar Allwyn Colony, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.06 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹20.69 Lakh (net margin 6.8%) and EBITDA of ₹33.57 Lakh (EBITDA margin 11%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 1% over five years.
The company has about 16 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹53 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medrexpharma.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressGround & First Floor H.No:4 – 32 – 41/149/1 Raghavendra Nagar Allwyn Colony, Hyderabad, Telangana, India – 500072
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Medrexcare Pharma Private Limited
The main business activity of Medrexcare Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Medrexcare Pharma Private Limited FY 2025 filings available
Medrexcare Pharma Private Limited reported revenue of ₹3.06 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Medrexcare Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 15% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Medrexcare Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹33.57 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹20.69 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Medrexcare Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 6.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Medrexcare Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Medrexcare Pharma Private Limited
Medrexcare Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Efpia Medicine Private Limited | ₹3.08 Cr (FY 2025) | •••• | •••• | •••• | Panchkula, Haryana, India | |
| Shubh Pharma Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | -43.0% | •••• | Thane, Maharashtra, India |
| Venova Pharmaceuticals Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | New Delhi, Delhi, India |
| Sitnez Biocare Private Limited | ₹3.07 Cr (FY 2025) | •••• | •••• | -11.0% | •••• | Chandigarh, India |
| Seegakula Pharmaceuticals Private Limited | ₹3.07 Cr (FY 2022) | •••• | •••• | 11.0% | •••• | Bengaluru, Karnataka, India |
| Medrexcare Pharma Private Limited this company | ₹3.06 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Hyderabad, Telangana, India |
| Ralington Pharma LLP | ₹3.06 Cr (FY 2021) | •••• | •••• | 364.0% | •••• | Sanand, Gujarat, India |
| Alisier Drugs Private Limited | ₹3.06 Cr (FY 2024) | •••• | •••• | -4.0% | •••• | Ambala Cantt, Haryana, India |
| Verdeus Naturals Private Limited | ₹3.05 Cr (FY 2025) | •••• | •••• | •••• | Mysore, Karnataka, India | |
| Teblik Drugs Private Limited | ₹3.05 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Indore, Madhya Pradesh, India |
| Nway Biotech Private Limited | ₹3.04 Cr (FY 2025) | •••• | •••• | 141.0% | •••• | Aurangabad, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Medrexcare Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Medrexcare Pharma Private Limited
Medrexcare Pharma Private Limited is audited by THAMMANAANDCO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| THAMMANAANDCO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Medrexcare Pharma Private Limited
Medrexcare Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anitha Puritipati | Director | 28 Sep 2012 | 14 Years 0 Months | Current |
| Bantroth Rammohan Reddy | Director | 28 Sep 2012 | 14 Years 0 Months | Current |
Ownership and Shareholding of Medrexcare Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Medrexcare Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 May 2023 | Others | ₹53 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Medrexcare Pharma Private Limited
Medrexcare Pharma Private Limited has a workforce of 16 employees as of Apr 01, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Medrexcare Pharma Private Limited
Medrexcare Pharma has one previous CIN (Corporate Identification Number): U24232AP2012PTC083331. The current CIN is U24232TG2012PTC083331, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2012PTC083331 | Current |
| U24232AP2012PTC083331 | Previous |
Recent Activity on Medrexcare Pharma Private Limited
Medrexcare Pharma Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Anitha Puritipati was appointed as Director on 28 Sep 2012.
Credit Ratings, Litigation & Regulatory Alerts for Medrexcare Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Medrexcare Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Medrexcare Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Medrexcare Pharma Private Limited
Medrexcare Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICM1811G1ZQ | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Medrexcare Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medrexcare Pharma Private Limited
Medrexcare Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 September 2012 (14+ years old) and is registered under CIN U24232TG2012PTC083331.
Medrexcare Pharma reported revenue of ₹3.06 Cr for FY 2025 (up 15% YoY).
Medrexcare Pharma has 2 current directors:
- Anitha Puritipati - Director
- Bantroth Rammohan Reddy - Director
Medrexcare Pharma reported a net profit of ₹20.69 Lakh (net margin 6.8%) and EBITDA of ₹33.57 Lakh (EBITDA margin 11%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Medrexcare Pharma is -9% over three years and 1% over five years. In the latest year (FY 2025) revenue rose 15%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Medrexcare Pharma is 36AAICM1811G1ZQ, registered in Telangana.
The CIN (Corporate Identification Number) of Medrexcare Pharma is U24232TG2012PTC083331. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medrexcare Pharma was incorporated on 28 September 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Medrexcare Pharma by revenue are Efpia Medicine Private Limited, Shubh Pharma Private Limited, Venova Pharmaceuticals Private Limited, Sitnez Biocare Private Limited, Seegakula Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Anitha Puritipati was appointed as Director on 28 Sep 2012. Bantroth Rammohan Reddy was appointed as Director on 28 Sep 2012.
Medrexcare Pharma can be reached through the website medrexpharma.co.in. Its registered office is in Hyderabad, Telangana, India.